default author photo

Jia-Xin Lin

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

28

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Patient-Centric, Open-Label, Multicenter, Phase Ii Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients with Locally Advanced or Metastatic Alk-Positive Non-Small Cell Lung Cancer (Ctong2203)

Number of pages: 18 Posted: 05 Apr 2025
Jia-Xin Lin, Qing Zhou, Hong-Hong Yan, Anwen Liu, Guo-Wu Wu, Qian Chu, Yingying Du, Jiuwei Cui, Ying Cheng, Y. Yang, Haipeng Xu, Hai-Yan Tu, Yi-Long Wu and Si-Yang Maggie Liu
affiliation not provided to SSRN, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, affiliation not provided to SSRN, Nanchang University - Department of Medical Oncology, affiliation not provided to SSRN, Huazhong University of Science and Technology - Department of Oncology, Anhui Medical University - Department of Oncology, Jilin University (JLU) - Cancer Center, Jilin Cancer Hospital - Department of Oncology, Southwest Jiaotong University, Fujian Medical University - Department of Thoracic Oncology, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Southern Medical University and Southern Medical University
Downloads 28 (1,359,097)

Abstract:

Loading...

non-small cell lung cancer, lorlatinib, ALK-positive, first-line treatment, Patient-centric trial